H. Pylori Infection Clinical Trial
— SIGES-01Official title:
A Prospective Cohort Study of Early Detection and Screening Strategy for Gatric Cancer in Sichuan Province China (SIGES-01)
To establish prospective cohort of healthy population and corresponding serum sample bank in Sichuan province to provide platform for exploring early diagnosis and screening strategy of gastric cancer by a prospective cohort study.
Status | Recruiting |
Enrollment | 30000 |
Est. completion date | December 31, 2020 |
Est. primary completion date | December 31, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Inhabitant in Sichuan province in China (length of residence > 10 years); 2. Complete physical examination in our hospital, the outcomes was asymptomatic and cancer free healthy individuals; 3. Age between 20 and 70; 4. With normal cognitive and communication ability; 5. Without gastroscopy during recruitment, physical examination item including gastroscopy enrolled in prospective cohort study; 6. Wiling to accept 1-2 times routine physical examination in our hospital; 7. Agree to accept the follow-up of our project group; Exclusion Criteria: 1. With history of malignant tumor; 2. Refuse to donate blood specimen; 3. With serious comorbidity and/or finite life (less than 5 years); 4. Request to retreat from this study; |
Country | Name | City | State |
---|---|---|---|
China | Jian-Kun Hu | Chengdu | Sichuan |
Lead Sponsor | Collaborator |
---|---|
Jian-Kun Hu | Xin-Zu Chen |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The number of new cases of gastric carcinoma | The new cases of gastric and other epidermal malignant tumor | 5 years | |
Secondary | Time of finding nee cases | The time during SIGES when finding nee gastric cancer and relative disease | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06045494 -
The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21
|
N/A | |
Not yet recruiting |
NCT01449500 -
Supplementation With L. Reuteri in H. Pylori Infected Adults
|
N/A | |
Completed |
NCT01234389 -
Immediate Detection of Helicobacter Infection With a New Electrochemical System.
|
N/A | |
Not yet recruiting |
NCT05387005 -
Screening Strategy for Gastric Cancer Prevention
|
N/A | |
Not yet recruiting |
NCT02761005 -
Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori
|
Phase 2 | |
Recruiting |
NCT03142620 -
Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study
|
Phase 3 | |
Withdrawn |
NCT02090738 -
A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide
|
Phase 2 | |
Recruiting |
NCT01335334 -
H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study
|
Phase 4 | |
Recruiting |
NCT05544396 -
Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.
|
N/A | |
Recruiting |
NCT04713670 -
Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection
|
Phase 4 | |
Recruiting |
NCT06045832 -
Oral Helicobacter Pylori Eradication
|
N/A | |
Completed |
NCT05453994 -
Bismuth for PCAB-based H. Pylori Eradication
|
||
Recruiting |
NCT02328131 -
European Registry on the Management of Helicobacter Pylori Infection
|
||
Completed |
NCT00197457 -
Pepsinogens as the Early Marker of H. Pylori Eradication
|
Phase 2 | |
Not yet recruiting |
NCT06412640 -
Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori
|
Phase 4 | |
Completed |
NCT04036838 -
ARJ C13 Urea Breath Test System
|
Phase 2 | |
Completed |
NCT06050824 -
A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection
|
Phase 4 | |
Completed |
NCT02767479 -
Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori
|
Phase 3 | |
Completed |
NCT01505127 -
Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori
|
Phase 3 | |
Recruiting |
NCT05176821 -
Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection
|
N/A |